140 related articles for article (PubMed ID: 36632922)
1. Amphotericin B and monoacyl-phosphatidylcholine form a stable amorphous complex.
Liu X; Berthelsen R; Bar-Shalom D; Kjellerup Lind T; Doutch J; Müllertz A
Int J Pharm; 2023 Feb; 633():122601. PubMed ID: 36632922
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro evaluation of an infant friendly self-nanoemulsifying drug delivery system (SNEDDS) loaded with an amphotericin B-monoacyl phosphatidylcholine complex for oral delivery.
Liu X; Müllertz A; Bar-Shalom D; Berthelsen R
Int J Pharm; 2024 May; 660():124286. PubMed ID: 38815640
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B.
Ménez C; Legrand P; Rosilio V; Lesieur S; Barratt G
Mol Pharm; 2007; 4(2):281-8. PubMed ID: 17397240
[TBL] [Abstract][Full Text] [Related]
5. Monoacyl phosphatidylcholine inhibits the formation of lipid multilamellar structures during in vitro lipolysis of self-emulsifying drug delivery systems.
Tran T; Siqueira SDVS; Amenitsch H; Rades T; Müllertz A
Eur J Pharm Sci; 2017 Oct; 108():62-70. PubMed ID: 27890596
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method.
Zhou Y; Fang Q; Niu B; Wu B; Zhao Y; Quan G; Pan X; Wu C
Colloids Surf B Biointerfaces; 2018 Dec; 172():372-379. PubMed ID: 30193196
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
8. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
[TBL] [Abstract][Full Text] [Related]
9. Development of an amphotericin B micellar formulation using cholesterol-conjugated styrene-maleic acid copolymer for enhancement of blood circulation and antifungal selectivity.
Banshoya K; Kaneo Y; Tanaka T; Yamamoto S; Maeda H
Int J Pharm; 2020 Nov; 589():119813. PubMed ID: 32871218
[TBL] [Abstract][Full Text] [Related]
10. Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.
Faustino C; Pinheiro L
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31906268
[TBL] [Abstract][Full Text] [Related]
11. Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug Delivery.
Thanki K; Date T; Jain S
ACS Biomater Sci Eng; 2023 Jun; 9(6):2879-2890. PubMed ID: 33587853
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN; Goa KL; Coukell AJ
Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B formulations: a comparative review of efficacy and toxicity.
Hamill RJ
Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into the formation of drug-monoacyl phosphatidylcholine solid dispersions for oral delivery.
Gautschi N; Van Hoogevest P; Kuentz M
Eur J Pharm Sci; 2017 Oct; 108():93-100. PubMed ID: 27240778
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Characterization of Spherical Amorphous Solid Dispersion with Amphotericin B.
Mehenni L; Lahiani-Skiba M; Ladam G; Hallouard F; Skiba M
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30453493
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of amphotericin B nanosuspensions for oral administration through a simple top-down method.
Yang Z; Liu M; Chen J; Fang W; Zhang Y; Yuan M; Gao J
Curr Pharm Biotechnol; 2014; 15(6):569-76. PubMed ID: 25005312
[TBL] [Abstract][Full Text] [Related]
18. Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat.
Dangi JS; Vyas SP; Dixit VK
Drug Dev Ind Pharm; 1998 Jul; 24(7):631-5. PubMed ID: 9876507
[TBL] [Abstract][Full Text] [Related]
19. Effect of glycyrrhizinate on dissolution behavior and rectal absorption of amphotericin B in rabbits.
Tanaka M; Takahashi M; Kuwahara E; Koyama O; Ohkubo K; Yotsuyanagi T
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1559-62. PubMed ID: 1394677
[TBL] [Abstract][Full Text] [Related]
20. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
